Literature DB >> 20935507

Nitrogen anabolism underlies the importance of glutaminolysis in proliferating cells.

Meng Meng1, Shuyang Chen, Taotao Lao, Dongming Liang, Nianli Sang.   

Abstract

Glutaminolysis and Warburg effect are the two most noticeable metabolic features of tumor cells whereas their biological significance in cell proliferation remains elusive. A widely accepted current hypothesis is that tumor cells use glutamine as a preferred carbon source for energy and reducing power, which has been used to explain both glutaminolysis and the Warburg effect. Here we provide evidence to show that supplying nitrogen, not the carbon skeleton, underlies the major biological importance of glutaminolysis for proliferating cells. We show alternative nitrogen supplying mechanisms rescue cell proliferation in glutamine-free media. Particularly, we show that ammonia is sufficient to maintain a long-term survival and proliferation of Hep3B in glutamine-free media. We also observed that nitrogen source restriction repressed carbon metabolic pathways including glucose utilization. Based on these new observations and metabolic pathways well established in published literature, we propose an alternative model that cellular demand for glutamate as a key molecule in nitrogen anabolism is the driving force of glutaminolysis in proliferating cells. Our model suggests that the Warburg effect may be a metabolic consequence secondary to the nitrogen anabolism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20935507      PMCID: PMC3047752          DOI: 10.4161/cc.9.19.13139

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  51 in total

1.  cDNA cloning, genomic structure, chromosomal mapping, and functional expression of a novel human alanine aminotransferase.

Authors:  Rong-Ze Yang; Greorghe Blaileanu; Barbara C Hansen; Alan R Shuldiner; Da-Wei Gong
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

Review 2.  Rethinking the Warburg effect with Myc micromanaging glutamine metabolism.

Authors:  Chi V Dang
Journal:  Cancer Res       Date:  2010-01-19       Impact factor: 12.701

3.  Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect.

Authors:  Yijun Chen; Rob Cairns; Ioanna Papandreou; Albert Koong; Nicholas C Denko
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

4.  GCN2 protein kinase is required to activate amino acid deprivation responses in mice treated with the anti-cancer agent L-asparaginase.

Authors:  Piyawan Bunpo; Allison Dudley; Judy K Cundiff; Douglas R Cavener; Ronald C Wek; Tracy G Anthony
Journal:  J Biol Chem       Date:  2009-09-25       Impact factor: 5.157

5.  Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth.

Authors:  Taro Hitosugi; Sumin Kang; Matthew G Vander Heiden; Tae-Wook Chung; Shannon Elf; Katherine Lythgoe; Shaozhong Dong; Sagar Lonial; Xu Wang; Georgia Z Chen; Jianxin Xie; Ting-Lei Gu; Roberto D Polakiewicz; Johannes L Roesel; Titus J Boggon; Fadlo R Khuri; D Gary Gilliland; Lewis C Cantley; Jonathan Kaufman; Jing Chen
Journal:  Sci Signal       Date:  2009-11-17       Impact factor: 8.192

6.  PKM2 tyrosine phosphorylation and glutamine metabolism signal a different view of the Warburg effect.

Authors:  Chi V Dang
Journal:  Sci Signal       Date:  2009-11-17       Impact factor: 8.192

7.  The reverse Warburg effect: aerobic glycolysis in cancer associated fibroblasts and the tumor stroma.

Authors:  Stephanos Pavlides; Diana Whitaker-Menezes; Remedios Castello-Cros; Neal Flomenberg; Agnieszka K Witkiewicz; Philippe G Frank; Mathew C Casimiro; Chenguang Wang; Paolo Fortina; Sankar Addya; Richard G Pestell; Ubaldo E Martinez-Outschoorn; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2009-12-05       Impact factor: 4.534

8.  Glutamine-dependent anapleurosis dictates glucose uptake and cell growth by regulating MondoA transcriptional activity.

Authors:  Mohan R Kaadige; Ryan E Looper; Sadhaasivam Kamalanaadhan; Donald E Ayer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-17       Impact factor: 11.205

9.  Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases.

Authors:  Peppi Koivunen; Maija Hirsilä; Volkmar Günzler; Kari I Kivirikko; Johanna Myllyharju
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

10.  The GCN2 eIF2alpha kinase is required for adaptation to amino acid deprivation in mice.

Authors:  Peichuan Zhang; Barbara C McGrath; Jamie Reinert; DeAnne S Olsen; Li Lei; Sangeeta Gill; Sheree A Wek; Krishna M Vattem; Ronald C Wek; Scot R Kimball; Leonard S Jefferson; Douglas R Cavener
Journal:  Mol Cell Biol       Date:  2002-10       Impact factor: 4.272

View more
  45 in total

1.  Glutaminolysis and carcinogenesis of oral squamous cell carcinoma.

Authors:  Marcel Cetindis; Thorsten Biegner; Adelheid Munz; Peter Teriete; Siegmar Reinert; Martin Grimm
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-02-07       Impact factor: 2.503

2.  ErbB2 activation upregulates glutaminase 1 expression which promotes breast cancer cell proliferation.

Authors:  Shuo Qie; Clarissa Chu; Weihua Li; Chenguang Wang; Nianli Sang
Journal:  J Cell Biochem       Date:  2014-03       Impact factor: 4.429

Review 3.  Current views on cell metabolism in SDHx-related pheochromocytoma and paraganglioma.

Authors:  Ales Vicha; David Taieb; Karel Pacak
Journal:  Endocr Relat Cancer       Date:  2014-05-08       Impact factor: 5.678

Review 4.  Mitochondrial metabolism inhibitors for cancer therapy.

Authors:  Emma E Ramsay; Philip J Hogg; Pierre J Dilda
Journal:  Pharm Res       Date:  2011-09-15       Impact factor: 4.200

5.  Glutamine depletion and glucose depletion trigger growth inhibition via distinctive gene expression reprogramming.

Authors:  Shuo Qie; Dongming Liang; Chengqian Yin; Weiting Gu; Meng Meng; Chenguang Wang; Nianli Sang
Journal:  Cell Cycle       Date:  2012-08-30       Impact factor: 4.534

Review 6.  Role of glutamine in cancer: therapeutic and imaging implications.

Authors:  Kartik N Rajagopalan; Ralph J DeBerardinis
Journal:  J Nucl Med       Date:  2011-06-16       Impact factor: 10.057

Review 7.  Therapeutic strategies impacting cancer cell glutamine metabolism.

Authors:  Michael J Lukey; Kristin F Wilson; Richard A Cerione
Journal:  Future Med Chem       Date:  2013-09       Impact factor: 3.808

8.  Normoxic accumulation of HIF1α is associated with glutaminolysis.

Authors:  Matthias Kappler; Ulrike Pabst; Swetlana Rot; Helge Taubert; Henri Wichmann; Johannes Schubert; Matthias Bache; Claus Weinholdt; Uta-Dorothee Immel; Ivo Grosse; Dirk Vordermark; Alexander W Eckert
Journal:  Clin Oral Investig       Date:  2016-03-09       Impact factor: 3.573

Review 9.  Histone deacetylase inhibitors: the epigenetic therapeutics that repress hypoxia-inducible factors.

Authors:  Shuyang Chen; Nianli Sang
Journal:  J Biomed Biotechnol       Date:  2010-12-05

10.  The real face of HIF1α in the tumor process.

Authors:  Matthias Kappler; Helge Taubert; Johannes Schubert; Dirk Vordermark; Alexander W Eckert
Journal:  Cell Cycle       Date:  2012-09-17       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.